Stocktoria
Genenta Science S.p.A. GNTA
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2021-12-15
Genenta Science S.p.A. statistics & valuation
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Return on assets | -20.5% | -60.1% | -52.1% | -25.4% | -13.8% |
| Return on equity | -29.9% | -71.3% | -57.0% | -27.2% | -14.2% |
| Current ratio | 14.16 | 6.89 | 12.25 | 14.53 | 34.15 |
Source: SEC EDGAR filings · CIK 0001838716 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.